Consequently, targeting ACC1 or its downstream metabolic pathways could be a promising strategy for reprogramming tumor metabolism, enhancing immune cell functionality, and improving the efficacy of immune checkpoint blockade therapies. Here, ACACA is linked to neoplasm.